Viewing Study NCT00492167


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-04-11 @ 1:55 PM
Study NCT ID: NCT00492167
Status: COMPLETED
Last Update Posted: 2022-03-07
First Post: 2007-06-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module